Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Regulatory
Adrucil — FLUOROPLEX
Application NDA016765 (NDA)
Adrucil — EFUDEX
Application NDA016831 (NDA)
Adrucil — FLUOROPLEX
Application NDA016988 (NDA)
Adrucil — ADRUCIL
Application NDA017959 (NDA)
Adrucil — CARAC
Application NDA020985 (NDA)
Adrucil — TOLAK
Application NDA022259 (NDA)
Adrucil — FLUOROURACIL
Application NDA012209 (NDA)
Adrucil — FAVLYXA
Application NDA220201 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)